ReviewHeart failure reviews2019
The long non-coding road to endogenous cardiac regeneration.
Review in Heart failure reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- 3D bioprinting of microfluidic systems for cardiac regenerative medicine: from biofabrication to organ-on-a-chip.Journal of biological engineering · 2026Review
- The Role of Long Non-Coding RNAs in Cardiovascular Diseases.International journal of molecular sciences · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human heart has a markedly low regenerative capacity, leaving patients who suffered from cardiac insults vulnerable to heart failure. The inability to regenerate lost myocardium is accompanied by extensive remodeling that leads to further deterioration in cardiac functions and structure. Although adult mammals seem to lack the ability to regenerate, some lower vertebrates have a cardio-regenerative potential. Emerging studies revealed that mammals do have the ability to undergo endogenous cardiac regeneration during development and shortly after birth. Later, it was proven that the source of the new cardiomyocytes is the proliferation of the pre-existing cardiomyocyte pool. Research is currently focused on finding suitable methods to restore this lost potential in adulthood and enhancing the proliferative capacity of cardiomyocytes. Long non-coding RNAs (lncRNAs) are critical functionally diverse epigenetic regulators capable of either activating or repressing gene expression. LncRNAs have been previously implicated in cardiac development, lineage commitment, and aging. Recent reports suggest that lncRNAs are capable of inducing endogenous cardiac regeneration through manipulating gene expression in cardiomyocytes. This review gives a concise overview of endogenous cardiac regeneration. It further summarizes and critically appraises the current literature on the roles of lncRNAs in endogenous cardiac regeneration and the challenges that face the field.
Indexed as
Identifiers
30900115What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.